Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

This study has been completed.
Information provided by:
ZymoGenetics Identifier:
First received: October 29, 2004
Last updated: March 6, 2009
Last verified: March 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)